
OR WAIT null SECS
© 2025 MJH Life Sciences™ and Pharmaceutical Commerce - Biopharma Business News, Market Insights. All rights reserved.
Jay McHarg, CEO of AeroSafe Global, reacts to the next generation of pharma delivery using innovations such as reusable packaging, integrated delivery systems, and real-time delivery intelligence.
Sponsored by AeroSafe Global
At AeroSafe, says Jay McHarg, CEO of AeroSafe Global, the team’s passion is deeply connected to the future of pharmaceutical delivery. Every day, whether in logistics, engineering, supply chain, or assembling delivery packaging, the team focuses on one mission: ensuring patients and providers receive the care they need, when they need it.
This dedication, he says, is driven by a strong sense of purpose. While AeroSafe does not manufacture medications, it plays a critical role in delivering them safely and on time. Team members take pride in their work and embrace urgent requests, recognizing the importance of their role in supporting patient care.
Looking ahead, McHarg explains that AeroSafe is shaping the next generation of pharma delivery through innovations such as reusable packaging, integrated delivery systems, and real-time delivery intelligence. These strategies, he adds, improve reliability, sustainability, and patient trust, helping supply chain leaders meet the evolving needs of specialty therapies while redefining success in the industry.
Did you miss the beginning of this interview? Click here.
Related Content: